PREDICTIVE ONCOLOGY INC (POAI)

Company Profile

Predictive Oncology, Inc. engages in the application of artificial intelligence medicine business and provision of cleared STREAMWAY System for automated, direct-to-drain medical fluid disposal, and associated products. The company is headquartered in Pittsburgh, Pennsylvania and currently employs 31 full-time employees. The company went IPO on 2009-12-18. The firm operates in three segments based on location and specialty: the Pittsburgh segment provides services that include the application of AI using its biobank of 150,000+ cancer tumor samples. Pittsburgh also utilizes three-dimensional (3D) culture models in drug development. The Birmingham segment provides services and research using a self-contained, automated system that conducts high-throughput, self-interaction chromatography screens, using additives and excipients included in protein formulations resulting in soluble and physically stable formulations of biologics focused on solubility improvements, stability studies, and protein production. The Eagan (Minnesota) segment consists of the production of the STREAMWAY System for automated fluid waste management, direct-to-drain medical fluid disposal, and associated products.

Company Info

PREDICTIVE ONCOLOGY INC

91 43Rd Street, Suite 110

Pittsburgh PENNSYLVANIA 55121

P: 14124321500

CEO: Carl Schwartz

Employees: 31

Website: https://predictive-oncology.com/